ArticleCells2022

Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance.

Joaquim Vives et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.